BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2022 Earnings Conference Call February 21, 2023 8:30 AM ET Company Participants John Bluth - Investor Relations Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Helen Thackray - Chief R&D Officer Conference Call Participants Jessica Fye - JPMorgan Tazeen Ahmad - Bank of America Chris Raymond - Piper Sandler Liisa Bayko - Evercore ISI Jon Wolleben - JMP Securities Ken Cacciatore - Cowen & ...